[1] European Association For The study of the liver.EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol, 2012,57: 167-185.
[2] Liaw YF.Natural history of chronic hepatitis B virus infection and long-term outcome under treatment.Liver Int, 2009, 29 Suppl 1: 100-107.
[3] Lok AS,McMahon BJ.Chronic hepatitis B:update 2009.Hepatology,2009,50:661-662.
[4] 刘娜,徐光华,张雅芳.影响慢性乙型肝炎病毒感染自然史因素的研究进展.放射免疫学杂志,2009,22: 503-506.
[5] 庄辉.慢性乙型肝炎病毒感染及其防治.中华肝脏病杂志,2005,13:324-325.
[6] 沈晶晶,翼英,关晓蕾,等.HLA-DRB10与中国人慢性乙肝关联. 中华微生物学和免疫学杂志,1999,19:58-59.
[7] 涂正坤,吴雄文,刘敏,等.湖北汉族人群对乙肝疫苗应答的水平与HLA Ⅰ类分子多态性的相关研究.中国免疫学杂志,1999,15:20-22.
[8] Thio C L,Carrington M,Marti D,et al.Class Ⅱ HLA alleles and hepatitis B virus persistence in African Americans.J Infect Dis,1999,179:1004-1006.
[9] Thio CL,Thomas DL,Karacki P,et al.Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection.J Virol,2003,77:12083-12087.
[10] 周小平,李爱月,陈勇,等.HBV DNA及HBV抗原在血清HBV标志物阴性肝炎肝组织中表达的研究.细胞与分子免疫学杂志,2002,18:39-40.
[11] Hui CK,Leung N,Yuen ST,et al.Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase.Hepatology,2007,46:395-401.
[12] Nguyen T,Thompson AJ,Bowden S, et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia.J Hepatol,2010,52: 508-513.
[13] Chen CJ,Yang HI,Su J,et al.Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.JAMA,2006,295:65-73.
[14] Chu CM,Liaw YF.Chronic hepatitis B virus infection acquired in childhood:special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion.J Viral Hepat,2007,14:147-152. |
